Proactive Investors - Run By Investors For Investors

Sativa opens first CBD wellness store with trading ahead of expectations

Sativa said the roll out of the Goodbody store network will drive revenues
cannabis
The store sells CBD infused coffee and tea

Sativa Group PLC (LON:SATI) opened its first cannabidiol (CBD) wellness retail outlet in Bath at the weekend and initial trading was ahead of expectations.

The Goodbody Wellness store was launched on Friday evening by Crispin Blunt, MP for Reigate and co-chair of the All Party Parliamentary Group for Drug Policy Reform.

READ: Sativa says 2019 first quarter revenues exceeding total revenues in the group’s first year of trading

Sativa said footfall, turnover and average transaction value in the first weekend of trading exceeded expectations. 

The store stocks more than 50 CBD products, including oils, vapes, skincare, tinctures, balms and capsules. It also sells CBD infused coffee and tea.

“Goodbody Wellness is the UK's first prestige CBD store and the Bath launch was a great success, with customer feedback being that the format is exactly what they wanted,” said Sativa chief executive Geremy Thomas.

He added: "Our product development and manufacturing capability allows multiple routes to market and the roll out of our Goodbody store network will drive revenues. 

“Bath is the first of three pilot stores after which the Company intends to roll-out a national franchise network, because the directors believe that this is the fastest and least capital-intensive route to a national footprint."  

Join Proactive’s Crypto, Blockchain and Cannabis Telegram group here
View full SATI profile View Profile

Sativa Group PLC Timeline

Related Articles

cancer cell
Wed
The San Diego-based company has developed a patented liquid biopsy technology called Target Selector the detects and isolates cancer biomarkers such as circulating tumor cells (CTCs) and cell-free circulating tumor DNA (ctDNA)
pills
April 12 2019
The biotechnology company is developing a platform of unique drugs designed to prevent serious gastrointestinal damage and bleeding caused by chronic naproxen use
harley street
May 10 2019
Work at Advanced Onco’s Harley Street facility is due to complete within the next few months, and the first patient treated by LIGHT is slated for the second half of 2020

© Proactive Investors 2019

Proactive Investors Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use